Corporate Biocon Limited April 21, 2026 Biocon Limited has informed the Exchange regarding a press release dated April 21, 2026, titled “Biocon Receives Health Canada Approval of Bosaya (Denosumab) and Vevzuo (Denosumab), Biosimilars to Prolia® and Xgeva®”. |SUBJECT: Press Release Post navigation Coforge Limited Bharat Wire Ropes Limited Related Posts UNO Minda Limited UNO Minda Limited has informed the Exchange about change in Management |SUBJECT: Change in Management March 30, 2026 Baazar Style Retail Limited Baazar Style Retail Limited has informed the Exchange regarding ‘ Intimation Of Opening Of A… April 12, 2026 Aether Industries Limited Further, with reference to the intimation dated March 10, 2026 submitted vide Ref. No. AIL/SE/71/2025-26,… March 20, 2026 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
UNO Minda Limited UNO Minda Limited has informed the Exchange about change in Management |SUBJECT: Change in Management March 30, 2026
Baazar Style Retail Limited Baazar Style Retail Limited has informed the Exchange regarding ‘ Intimation Of Opening Of A… April 12, 2026
Aether Industries Limited Further, with reference to the intimation dated March 10, 2026 submitted vide Ref. No. AIL/SE/71/2025-26,… March 20, 2026